|
LONRF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.13470000062676E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.30849994465166E-09 |
| Normal-vs-Stage2 |
3.48829964913477E-10 |
| Normal-vs-Stage3 |
1.75260028711932E-10 |
| Normal-vs-Stage4 |
9.8004049320366E-11 |
| Stage1-vs-Stage2 |
7.134400E-02 |
| Stage1-vs-Stage3 |
2.911700E-02 |
| Stage1-vs-Stage4 |
1.387610E-02 |
| Stage2-vs-Stage3 |
8.787200E-01 |
| Stage2-vs-Stage4 |
8.817800E-01 |
| Stage3-vs-Stage4 |
7.241200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.86149995418106E-09 |
| Normal-vs-AfricanAmerican |
3.581900E-03 |
| Normal-vs-Asian |
8.38800029434594E-10 |
| Caucasian-vs-AfricanAmerican |
2.797800E-01 |
| Caucasian-vs-Asian |
3.588200E-01 |
| AfricanAmerican-vs-Asian |
1.786160E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.16429985044897E-10 |
| Normal-vs-Female |
2.65930000242776E-09 |
| Male-vs-Female |
8.563700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.37460000049217E-08 |
| Normal-vs-Age(41-60Yrs) |
7.74309949491681E-10 |
| Normal-vs-Age(61-80Yrs) |
1.93269955595099E-10 |
| Normal-vs-Age(81-100Yrs) |
4.897900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.010200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.670300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.827200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.010800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.726200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.432800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.377900E-03 |
| Classical-VS-Follicular |
2.225000E-01 |
| Classical-VS-Other |
8.760200E-01 |
| Classical-VS-Normal |
1.10110000006713E-08 |
| Tall-VS-Follicular |
2.237800E-01 |
| Tall-VS-Other |
1.629370E-01 |
| Tall-VS-Normal |
1.00299990535291E-10 |
| Follicular-VS-Other |
5.766200E-01 |
| Follicular-VS-Normal |
3.31899996375284E-09 |
| Other-VS-Normal |
1.24830000003406E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.48990042525554E-10 |
| Normal-vs-N1 |
6.04400000048244E-08 |
| N0-vs-N1 |
1.212620E-01 |
|
|
